Cannabigerol Expression

Cannabigerol (CBG) expression refers to cannabis plants that produce notably elevated levels of cannabigerol, a non-intoxicating cannabinoid found in the cannabis plant. CBG is considered a minor cannabinoid in most modern cultivars, but certain genetic lines and breeding programs have selected for higher CBG phenotypes. Lineage records frequently report CBG-dominant strains emerging from crosses involving specific landrace genetics and controlled breeding for early-harvest cannabinoid profiles. CBG biosynthesis occurs early in the plant's development, making it biochemically significant for understanding cannabinoid pathway genetics. Breeders working in this category often use selective crosses and molecular markers to stabilize CBG-rich phenotypes for research and commercial cultivation programs.

Breeders targeting CBG expression typically select parent plants showing higher baseline CBG levels or use timing-based strategies such as early harvesting to maximize cannabigerol before conversion to other cannabinoids. Understanding CBG genetics helps breeders develop stable cultivars and contributes to broader cannabinoid diversity in the legal cannabis market.